Speech-Language Pathologists in Follansbee, WV Accepting Medicare

8 Speech-Language Pathologists found. Showing 1 - 8

Mrs. Amiee Louise Pendleton, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 840 Lee Rd, Follansbee, WV 26037 Phone: 304-527-1100

Richelle Lounder Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1098 Jefferson St, Follansbee, WV 26037 Phone: 304-527-2250

Mrs. Amy Corinne Ollila-roach, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 840 Lee Rd, Follansbee, WV 26037 Phone: 304-527-1100

Elise Marie Murphy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 840 Lee Rd, Follansbee, WV 26037 Phone: 304-527-1100

Beth Anne Tidd, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 840 Lee Rd, Follansbee, WV 26037 Phone: 304-527-1100

Rachel Wagner Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 840 Lee Road, Follansbee, WV 26037 Phone: 304-527-1100

Lynn M Gooch, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 840 Lee Rd, Follansbee, WV 26037 Phone: 304-527-1100

Jordan Welday, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 840 Lee Rd, Follansbee, WV 26037 Phone: 304-527-1100

News Archive

Study: Four risk factors estimated to reduce life expectancy in the U.S.

A study published this week in PLoS Medicine finds that four risk factors - smoking, high blood pressure, high blood sugar and obesity - explain a substantial amount of the disparity in life expectancy amongst the "Eight Americas", which are groups of the US population that can be defined by race, and location and socioeconomic features of counties they live in.

Researcher of LA BioMed elected to distinguished fellow status of SVS

Carlos E. Donayre, MD, a researcher at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), has been elected to distinguished fellow status of the Society for Vascular Surgery- (SVS).

CardiacAssist's new TandemLung oxygenator receives FDA clearance

CardiacAssist, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for its new TandemLung oxygenator, a medical device that acts as an artificial lung to infuse oxygen and remove carbon dioxide from the blood.

AstraZeneca to use THEW database for cardiac safety evaluation

AstraZeneca purchased a one-year membership to gain access to an international repository of data designed to aid industry and academic researchers developing new technologies to improve cardiac safety.

HyQ phase III study data in patients with primary immunodeficiencies presented at ACAAI meeting

Baxter International Inc. today announced the presentation of its phase III study data for HyQ, an investigational combination immunoglobulin (IG) product for use in patients with primary immunodeficiencies (PI).

Read more Medical News

› Verified 7 days ago